Cargando…
Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives
The incidence and mortality of cancer have increased over the past decades. Significant progress has been made in understanding the underpinnings of this disease and developing therapies. Despite this, cancer still remains a major therapeutic challenge. Current therapeutic research has targeted seve...
Autores principales: | Wdowiak, Kamil, Francuz, Tomasz, Gallego-Colon, Enrique, Ruiz-Agamez, Natalia, Kubeczko, Marcin, Grochoła, Iga, Wojnar, Jerzy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796159/ https://www.ncbi.nlm.nih.gov/pubmed/29320431 http://dx.doi.org/10.3390/ijms19010210 |
Ejemplares similares
-
Increased serum levels of Galectin-9 in patients with chronic lymphocytic leukemia
por: Wdowiak, Kamil, et al.
Publicado: (2019) -
C–C motif ligand 11 reduction in CLL patients serum after vitamin D supplementation
por: Kubeczko, Marcin, et al.
Publicado: (2016) -
Systemic Interleukins’ Profile in Early and Advanced Colorectal Cancer
por: Czajka-Francuz, Paulina, et al.
Publicado: (2021) -
The Value of Prolactin, a Panel of Cytokines, and the Soluble Human Epidermal Growth Factor Receptor 2 in the Prediction of Rapid Progression and Shorter Survival during Palliative Chemotherapy of Colorectal Cancer Patients
por: Cisoń-Jurek, Sylwia, et al.
Publicado: (2023) -
Exenatide modulates tumor–endothelial cell interactions in human ovarian cancer cells
por: Kosowska, Agnieszka, et al.
Publicado: (2017)